Format

Send to

Choose Destination
BMJ. 2018 Nov 15;363:k4691. doi: 10.1136/bmj.k4691.

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).

[No authors listed]
PMID:
30442772
DOI:
10.1136/bmj.k4691

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center